<p>Squares or diamonds to the left of the solid vertical line indicate benefit with bivalirudin. CI = confidence interval; RR = risk ratio; MACE = major adverse cardiovascular event; GPI = glycoprotein IIb/IIIa inhibitor.</p
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors h...
Background: Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and un...
<p>Squares or diamonds to the left of the solid vertical line indicate benefit with bivalirudin. CI ...
<p>The relative size of the data markers indicates the weight of the sample size from each study. CI...
suggested that it may be superior to heparins in reduc-ing bleeding complications. Additionally, biv...
<p>MACE: major adverse cardiac events; MACCE, major adverse cardiac and cerebrovascular events.</p
Aims: The aim of the study was to assess the safety and efficacy of Bivalirudin + Glycoprotein (Gp) ...
The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with thos...
The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with thos...
Sam J Lehman, Derek P ChewDepartment of Medicine, Flinders University, South Australia, AustraliaAbs...
<p>The relative size of the data markers indicates the weight of the sample size from each study. AC...
AIM: The purpose of our study was to evaluate the relative impact of bivalirudin on bleeding outcome...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
A variety of antithrombotic drugs are used during percutaneous coronary interventions (PCIs). We aim...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors h...
Background: Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and un...
<p>Squares or diamonds to the left of the solid vertical line indicate benefit with bivalirudin. CI ...
<p>The relative size of the data markers indicates the weight of the sample size from each study. CI...
suggested that it may be superior to heparins in reduc-ing bleeding complications. Additionally, biv...
<p>MACE: major adverse cardiac events; MACCE, major adverse cardiac and cerebrovascular events.</p
Aims: The aim of the study was to assess the safety and efficacy of Bivalirudin + Glycoprotein (Gp) ...
The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with thos...
The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with thos...
Sam J Lehman, Derek P ChewDepartment of Medicine, Flinders University, South Australia, AustraliaAbs...
<p>The relative size of the data markers indicates the weight of the sample size from each study. AC...
AIM: The purpose of our study was to evaluate the relative impact of bivalirudin on bleeding outcome...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
A variety of antithrombotic drugs are used during percutaneous coronary interventions (PCIs). We aim...
Percutaneous coronary intervention (PCI) is currently the standard of care for patients presenting w...
Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors h...
Background: Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and un...
DOI
Add to ORKG